23.06.2026 • Topics
Biopharma Innovation: From Bold Idea to Delivered Product
The biopharma sector has never lacked ambition. What it has often lacked is the infrastructure and manufacturing rigor to convert scientific promise into a product sitting reliably on a shelf. That gap between discovery and delivery is where the most consequential innovation is happening.
Christene A. Smith, Editor-in-Chief, CHEManager International
Continue with login
No account yet?
Register now for free and get full access to all exclusive articles from chemanager-online.com. With our newsletter we regularly send you top news from the chemistry industry as well as the latest e-issue.
Registermost read

US Tariffs Fatal for European Pharma
Trump's tariff policy is a considerable burden and a break with previous practice.

Lead or Lag: Europe’s AI Materials Race
How AI and Robotics are reshaping the race for materials discovery.

Pharma 4.0 – the Key Enabler for Successful Digital Transformation in Pharma
Part 1: Building a Business Case for Pharma 4.0

Q1 2025 Chemical Industry: Diverging Trends
The first quarter of 2025 highlights a continued divergence between the European and US chemical industries.

ISPE Good Practice Guide: Validation 4.0
The Validation 4.0 Guide provides a comprehensive approach to ensuring product quality and patient safety throughout a pharmaceutical product's lifecycle.









